Compare Pfizer Inc (PFE) vs Wipro Limited (WIT) Price & Performance

Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.

Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.

Wipro (WIT) trades at $1.73, down 4.42% today, reflecting bearish technical signals and recent earnings misses. The company maintains solid fundamentals with $131.35B net income (14.74% margin) and strong cash flow, though revenue declined to $890.88B in 2025. Recent partnerships with ABB and Databricks highlight strategic focus on AI and digital services.

Outlook remains cautious with analyst consensus leaning Hold (48%) amid earnings volatility. Key opportunities include AI partnerships and margin stability, while risks involve competitive pressures and client spending constraints. The stock offers value with P/E of 12.98 but requires monitoring of execution on growth initiatives.